BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 15976346)

  • 1. Transformed dermatofibrosarcoma protuberans: a clinicopathological study of eight cases.
    Szollosi Z; Nemes Z
    J Clin Pathol; 2005 Jul; 58(7):751-6. PubMed ID: 15976346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sarcomas arising in dermatofibrosarcoma protuberans: a reappraisal of biologic behavior in eighteen cases treated by wide local excision with extended clinical follow up.
    Goldblum JR; Reith JD; Weiss SW
    Am J Surg Pathol; 2000 Aug; 24(8):1125-30. PubMed ID: 10935653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrosarcomatous ("high-grade") dermatofibrosarcoma protuberans: clinicopathologic and immunohistochemical study of a series of 41 cases with emphasis on prognostic significance.
    Mentzel T; Beham A; Katenkamp D; Dei Tos AP; Fletcher CD
    Am J Surg Pathol; 1998 May; 22(5):576-87. PubMed ID: 9591728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fibrosarcomatous dermatofibrosarcoma protuberans: a clinicopathological analysis of 12 cases].
    Zhang J; Wu N; Xia C; Wei X; Shi QL; Zhou XJ; Ma J
    Zhonghua Bing Li Xue Za Zhi; 2013 Nov; 42(11):753-7. PubMed ID: 24447553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From Morphea to Dermatofibrosarcoma Protuberans.
    Crnarić I; Šitum M; Delaš Aždajić M; Vučić M; Buljan M
    Acta Dermatovenerol Croat; 2022 Sep; 30(2):113-115. PubMed ID: 36254545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic significance of fibrosarcomatous transformation in dermatofibrosarcoma protuberans.
    Abbott JJ; Oliveira AM; Nascimento AG
    Am J Surg Pathol; 2006 Apr; 30(4):436-43. PubMed ID: 16625088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dermatofibrosarcoma protuberans with fibrosarcomatous areas. A clinicopathologic study of nine cases and a comparison with allied tumors.
    Ding J; Hashimoto H; Enjoji M
    Cancer; 1989 Aug; 64(3):721-9. PubMed ID: 2545326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dermatofibrosarcoma protuberans with fibrosarcomatous areas. Molecular abnormalities of the p53 pathway in fibrosarcomatous transformation of dermatofibrosarcoma protuberans.
    Hisaoka M; Okamoto S; Morimitsu Y; Tsuji S; Hashimoto H
    Virchows Arch; 1998 Oct; 433(4):323-9. PubMed ID: 9808434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dermatofibrosarcoma protuberans with fibrosarcomatous areas: a clinico-pathologic and immunohistochemic study in four cases.
    Díaz-Cascajo C; Weyers W; Borrego L; Iñarrea JB; Borghi S
    Am J Dermatopathol; 1997 Dec; 19(6):562-7. PubMed ID: 9415611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dermatofibrosarcoma protuberans: an analysis of proliferative activity, DNA flow cytometry and p53 overexpression with emphasis on its progression.
    Sasaki M; Ishida T; Horiuchi H; MacHinami R
    Pathol Int; 1999 Sep; 49(9):799-806. PubMed ID: 10504551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3D-Histological evaluation of surgery in dermatofibrosarcoma protuberans and malignant fibrous histiocytoma: differences in growth patterns and outcome.
    Häfner HM; Moehrle M; Eder S; Trilling B; Röcken M; Breuninger H
    Eur J Surg Oncol; 2008 Jun; 34(6):680-6. PubMed ID: 17716851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dermatofibrosarcoma protuberans.
    Mendenhall WM; Zlotecki RA; Scarborough MT
    Cancer; 2004 Dec; 101(11):2503-8. PubMed ID: 15503305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dermatofibrosarcoma protuberans: A clinicopathologic analysis of patients treated and followed at a single institution.
    Bowne WB; Antonescu CR; Leung DH; Katz SC; Hawkins WG; Woodruff JM; Brennan MF; Lewis JJ
    Cancer; 2000 Jun; 88(12):2711-20. PubMed ID: 10870053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dermatofibrosarcoma protuberans: a population-based cancer registry descriptive study of 66 consecutive cases diagnosed between 1982 and 2002.
    Monnier D; Vidal C; Martin L; Danzon A; Pelletier F; Puzenat E; Algros MP; Blanc D; Laurent R; Humbert PH; Aubin F
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1237-42. PubMed ID: 17062038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dermatofibrosarcoma protuberans: a report on 29 patients treated by Mohs micrographic surgery with long-term follow-up and review of the literature.
    Snow SN; Gordon EM; Larson PO; Bagheri MM; Bentz ML; Sable DB
    Cancer; 2004 Jul; 101(1):28-38. PubMed ID: 15221986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of dermatofibrosarcoma protuberans with fibrosarcomatous transformation: an evidence-based review of the literature.
    Voth H; Landsberg J; Hinz T; Wenzel J; Bieber T; Reinhard G; Höller T; Wendtner CM; Schmid-Wendtner MH
    J Eur Acad Dermatol Venereol; 2011 Dec; 25(12):1385-91. PubMed ID: 21645124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pigmented fibrosarcomatous dermatofibrosarcoma protuberans (Bednar tumor). 3 case reports, analogy with the "conventional" type and review of the literature].
    Bisceglia M; Vairo M; Calonje E; Fletcher CD
    Pathologica; 1997 Jun; 89(3):264-73. PubMed ID: 9380420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome After Surgical Treatment of Dermatofibrosarcoma Protuberans (DFSP): Does it Require Extensive Follow-up and What is an Adequate Resection Margin?
    Alshaygy I; Mattei JC; Basile G; Griffin AM; Gladdy RA; Swallow CJ; Dickson BC; Wunder JS; Ferguson PC
    Ann Surg Oncol; 2023 May; 30(5):3106-3113. PubMed ID: 36658251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dermatofibrosarcoma protuberans treated with wide local excision and followed at a cancer hospital: prognostic significance of clinicopathologic variables.
    Erdem O; Wyatt AJ; Lin E; Wang X; Prieto VG
    Am J Dermatopathol; 2012 Feb; 34(1):24-34. PubMed ID: 21785324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A progression to dermatofibrosarcoma protuberans with a fibrosarcomatous component: a special reference to the chromosomal aberrations.
    Hamada M; Hirakawa N; Fukuda T; Furue M; Hori Y; Tsuneyoshi M
    Pathol Res Pract; 1999; 195(7):451-60. PubMed ID: 10448661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.